eamdacademy.org-FnRc-1792177817-w586196956 1792177817 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2024 3 1 Wei Chen Li Zhang 2024 10.68159/w586196956 https://eamdacademy.org/pub/journal/3/article/w586196956 Chen Y, Yang O, Sampat C, Bhalode P, Ramachandran R, Ierapetritou M. Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review. Processes. 2020;8(9):1088. Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, et al. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Comput Chem Eng. 2019;125:216-31. Bahrami F, Rossi RM, De Nys K, Defraeye T. An individualized digital twin of a patient for transdermal fentanyl therapy for chronic pain management. Drug Deliv Transl Res. 2023;13(9):2272-85. Defraeye T, Bahrami F, Ding L, Malini RI, Terrier A, Rossi RM, et al. Predicting transdermal fentanyl delivery using mechanistic simulations for tailored therapy. Front Pharmacol. 2020;11:585393. Hole G, Hole AS, McFalone-Shaw I. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process? Int J Pharm X. 2021;3:100095. Perno M, Hvam L, Haug A. Implementation of digital twins in the process industry: A systematic literature review of enablers and barriers. Comput Ind. 2022;134:103558. Jung EA, Park YJ, Kim JE. Application of continuous manufacturing for solid oral dosage forms. J Pharm Investig. 2023;53(4):457-74. Davidopoulou C, Ouranidis A. Pharma 4.0-artificially intelligent digital twins for solidified nanosuspensions. Pharmaceutics. 2022;14(10):2113. Yeom SB, Ha ES, Kim MS, Jeong SH, Hwang SJ, Choi DH, et al. Application of the discrete element method for manufacturing process simulation in the pharmaceutical industry. Pharmaceutics. 2019;11(8):414. Sacher S, Poms J, Rehrl J, Khinast JG. PAT implementation for advanced process control in solid dosage manufacturing—a practical guide. Int J Pharm. 2022;613:121408. Chen Y, Sampat C, Huang YS, Ganesh S, Singh R, Ramachandran R, et al. An integrated data management and informatics framework for continuous drug product manufacturing processes: A case study on two pilot plants. Int J Pharm. 2023;642:123086. Phalak P, Tomba E, Jehoulet P, Kapitan-Gnimdu A, Soladana PM, Vagaggini L, et al. Digital twin implementation for manufacturing of adjuvants. Processes. 2023;11(6):1717. Fischer RP, Volpert A, Antonino P, Ahrens TD. Digital patient twins for personalized therapeutics and pharmaceutical manufacturing. Front Digit Health. 2024;5:1302338. Badman C, Cooney CL, Florence A, Konstantinov K, Krumme M, Mascia S, et al. Why we need continuous pharmaceutical manufacturing and how to make it happen. J Pharm Sci. 2019;108(11):3521-3. Bhaskar A, Barros FN, Singh R. Development and implementation of an advanced model predictive control system into continuous pharmaceutical tablet compaction process. Int J Pharm. 2017;534(1-2):159-78. Celikovic S, Kirchengast M, Rehrl J, Kruisz J, Sacher S, Khinast J, et al. Model predictive control for continuous pharmaceutical feeding blending units. Chem Eng Res Des. 2020;154:101-14. Velez NL, Drennen JK, Anderson CA. Challenges, opportunities and recent advances in near infrared spectroscopy applications for monitoring blend uniformity in the continuous manufacturing of solid oral dosage forms. Int J Pharm. 2022;615:121462. Rangel-Gil RS, Nasrala-Álvarez JM, Romañach RJ, Méndez R. Blend uniformity monitoring in a continuous manufacturing mixing process for a low-dosage formulation using a stream sampler and near infrared spectroscopy. Int J Pharm. 2024;661:124478. Schiller JD, Müller MA. Suboptimal nonlinear moving horizon estimation. IEEE Trans Autom Control. 2022;68(4):2199-214. Mesbah A, Paulson JA, Lakerveld R, Braatz RD. Model predictive control of an integrated continuous pharmaceutical manufacturing pilot plant. Org Process Res Dev. 2017;21(6):844-54. Bahrami F, Rossi RM, De Nys K, Joerger M, Radenkovic MC, Defraeye T, et al. Implementing physics-based digital patient twins to tailor the switch of oral morphine to transdermal fentanyl patches based on patient physiology. Eur J Pharm Sci. 2024;195:106727. Malheiro V, Duarte J, Veiga F, Mascarenhas-Melo F. Exploiting pharma 4.0 technologies in the non-biological complex drugs manufacturing: innovations and implications. Pharmaceutics. 2023;15(11):2545. Zagalo DM, Simões S, Sousa J. Regulatory science approach in pharmaceutical development of follow-on versions of non-biological complex drug products. J Pharm Sci. 2022;111(10):2687-713. Perry C, Davis G, Conner TM, Zhang T. Utilization of physiologically based pharmacokinetic modeling in clinical pharmacology and therapeutics: an overview. Curr Pharmacol Rep. 2020;6(3):71-84. Arav Y. Advances in modeling approaches for oral drug delivery: Artificial intelligence, physiologically-based pharmacokinetics, and first-principles models. Pharmaceutics. 2024;16(8):978. Grimstein M, Yang Y, Zhang X, Grillo J, Huang SM, Zineh I, et al. Physiologically based pharmacokinetic modeling in regulatory science: an update from the US Food and Drug Administration's Office of Clinical Pharmacology. J Pharm Sci. 2019;108(1):21-5. Kuemmel C, Yang Y, Zhang X, Florian J, Zhu H, Tegenge M, et al. Consideration of a credibility assessment framework in model-informed drug development: potential application to physiologically-based pharmacokinetic modeling and simulation. CPT Pharmacometrics Syst Pharmacol. 2020;9(1):21-8. Liu YH, Chen YS, Tseng T, Jiang ML, Gau CS, Chang LC, et al. Regulatory considerations for generic products of non-biological complex drugs. J Food Drug Anal. 2023;31(1):20. Jelsch M, Roggo Y, Kleinebudde P, Krumme M. Model predictive control in pharmaceutical continuous manufacturing: A review from a user's perspective. Eur J Pharm Biopharm. 2021;159:137-42. Shebley M, Sandhu P, Emami Riedmaier A, Jamei M, Narayanan R, Patel A, et al. Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective. Clin Pharmacol Ther. 2018;104(1):88-110. Marshall S, Madabushi R, Manolis E, Krudys K, Staab A, Dykstra K, et al. Model-informed drug discovery and development: current industry good practice and regulatory expectations and future perspectives. CPT Pharmacometrics Syst Pharmacol. 2019;8(2):87-96. Markarian J. Modernizing pharma manufacturing. Pharm Technol. 2018;42(4):20-5. Nijsen MJ, Wu F, Bansal L, Bradshaw-Pierce E, Chan JR, Liederer BM, et al. Preclinical QSP modeling in the pharmaceutical industry: an IQ Consortium survey examining the current landscape. CPT Pharmacometrics Syst Pharmacol. 2018;7(3):135-46.